Skip to content

    MADRIGAL PHARMACEUTICALS (MDGL) stock price & financials

    View MDGL earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+25.6% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $62.17M
    $103.32M
    $137.25M
    $212.80M
    $287.27M
    +362.0%
    $321.08M
    +210.8%
    $311.34M
    +126.8%
    $364.25M
    +71.2%
    Strengthening
    Operating Profit
    -$116.30M
    -$67.00M
    -$79.31M
    -$47.20M
    -$113.97M
    +2.0%
    -$59.61M
    +11.0%
    -$92.72M
    -16.9%
    -$56.31M
    -19.3%
    Weakening
    Net Profit
    -$106.96M
    -$59.42M
    -$73.24M
    -$42.28M
    -$114.19M
    -6.8%
    -$58.58M
    +1.4%
    -$94.39M
    -28.9%
    -$57.94M
    -37.0%
    Weakening
    EPS
    $-4.92
    $-2.61
    $-1.50
    $-4.01
    +18.5%
    $-3.25
    -24.5%
    $-1.99
    -32.7%
    Weakening
    Other Income
    Interest
    $3.68M
    $3.50M
    $3.30M
    $3.26M
    $7.45M
    +102.5%
    $8.30M
    +137.2%
    $7.82M
    +137.2%
    $7.94M
    +143.3%
    Strengthening
    Depreciation
    Profit before Tax
    MarginsOPM
    -187.1%
    -64.8%
    -57.8%
    -22.2%
    -39.7%
    +78.8%
    -18.6%
    +71.4%
    -29.8%
    +48.5%
    -15.5%
    +30.3%
    Strengthening
    Tax
    ReturnsROIC
    4.8%
    2.6%
    3.3%
    1.9%
    5.1%
    +6.8%
    2.6%
    -1.4%
    4.2%
    +28.9%
    2.6%
    +37.0%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$57.38M$46.70M$54.00M$36.27M$331.55M$99.92M$100.02M$198.69M$292.73M
    Short-Term Investments
    Total Current Assets$485.20M$440.20M$285.16M$271.68M$361.37M$637.28M$1.03B$1.25B$1.20B
    Net PP&E$227.0K$1.86M$1.83M$1.65M$1.20M$3.27M$4.59M$6.44M$17.17M
    Goodwill
    Intangibles$0$4.73M$7.38M$7.19M
    Total Assets$485.43M$442.06M$287.00M$273.33M$362.57M$640.55M$1.04B$1.26B$1.24B
    LiabilitiesTotal Current Liabilities$8.44M$25.13M$46.56M$76.84M$115.89M$118.55M$169.28M$310.29M$374.20M
    Short-Term Debt
    Long-Term Debt$0$49.29M$115.48M$117.57M$339.88M$340.79M
    Long-Term Leases$361.0K$468.0K$387.0K$0$1.19M$1.02M$6.73M$5.92M
    Total Liabilities$8.44M$25.49M$47.02M$77.22M$165.18M$235.21M$287.86M$656.90M$720.92M
    EquityCommon Stock & APIC$2.0K$2.0K$2.0K$2.0K$2.0K$2.0K$2.0K$2.0K$2.0K
    Retained Earnings-$139.27M-$223.22M-$425.46M-$667.31M-$962.66M-$1.34B-$1.80B-$2.09B-$2.24B
    Total Equity$476.98M$416.56M$239.97M$196.11M$197.39M$405.33M$754.38M$602.69M$523.72M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$25.51M-$41.62M-$157.56M-$183.92M-$224.86M-$324.23M-$455.57M-$189.55M-$197.72M
    Cash from Investing-$380.08M$30.71M$159.78M-$5.05M$206.69M-$502.52M-$274.39M$32.32M$46.97M
    Cash from Financing$314.33M$235.0K$5.09M$171.24M$313.45M$595.12M$735.06M$255.98M$251.04M
    SummaryCapital Expenditure-$22.0K-$172.0K-$334.0K-$209.0K-$217.0K-$1.48M-$1.46M-$467.0K-$8.57M
    Free Cash Flow-$25.53M-$41.80M-$157.90M-$184.13M-$225.07M-$325.71M-$457.03M-$190.02M-$206.28M
    FCF Margin-253.7%-19.8%-16.1%

    Ratios